Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 404 followers

Latest posts

Last updated about 19 hours ago

FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER

about 19 hours ago

The FDA should strengthen the evidence required for drug approvals under its...

Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat

about 20 hours ago

The legal back-and-forth over migraine meds from Teva and Eli Lilly has...

Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale

about 21 hours ago

Astellas will close a stem cell therapy site. GSK is pushing a...

BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday

about 24 hours ago

The Biotechnology Innovation Organization has started the nationwide “​The Fight of Our...

Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign

1 day ago

The company highlights the features of its AI-powered Verily Me app in...

Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors

1 day ago

Innovative treatment options like targeted therapy and advanced molecular diagnostic techniques are...

Viatris, Teva kick off separate recalls over dissolution, raw material issues

1 day ago

Viatris and Teva Pharmaceutical Industries recently launched separate recalls related to dissolution...

AI simulates real-world HCP feedback on pharma content

1 day ago

Before committing to research, AI is helping pharma teams identify which concepts...

'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again

2 days ago

The anti-amyloid drug class has yielded some FDA approvals and plenty of...

Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy

2 days ago

Rather than relying on patient groups to make an impassioned plea, Roche...

Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel

2 days ago

Eli Lilly is wasting no time in pursuit of the next indication...

Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover

2 days ago

Omnicom Health has stamped its mark on the recently acquired FCB Health...